The Taipei Exchange’s Pioneer Stock Board welcomes a new addition in the biotech and healthcare category. LotusNine Medical Inc., a company integrating AI to develop innovative mobile medical devices and risk detection platforms, officially listed today (July 2).

LotusNine Medical is committed to creating a global mobile risk detection platform aimed at preventing cerebrovascular and cardiovascular neural diseases, offering the public proactive solutions for managing disease risk. The company’s core patents are based on technology transferred from National Taiwan University and have been developed into 12 proprietary mobile AI medical devices. These devices are designed to support both smart home environments and outdoor activities, making vibrant mental and physical health more accessible to all.

The company focuses on the development, design, and sales of mobile medical devices for detecting five major arterial obstructions, five key stroke risk factors, and three types of autonomic nervous system disorders.

By combining its self-developed mobile medical devices with its proprietary AI servers, LotusNine Medical enables a connected care model between individuals at home or on the move and practicing physicians. This system is particularly beneficial for rural households and people engaging in recreational activities like cycling or running. Through remote access, the AI server interprets clinical data using algorithms to deliver real-time feedback on heart rate variability and autonomic balance, enabling health monitoring anytime, anywhere and promoting public well-being.

Resource: 生醫新軍入列！深禾醫今登錄創櫃板 聚焦行動AI醫療器材